HLBBF
Price
$6.00
Change
+$0.65 (+12.15%)
Updated
Jul 2 closing price
Capitalization
4.85B
HLN
Price
$10.25
Change
-$0.01 (-0.10%)
Updated
Jul 3 closing price
Capitalization
38.4B
25 days until earnings call
Interact to see
Advertisement

HLBBF vs HLN

Header iconHLBBF vs HLN Comparison
Open Charts HLBBF vs HLNBanner chart's image
H. Lundbeck A/S
Price$6.00
Change+$0.65 (+12.15%)
Volume$333
Capitalization4.85B
Haleon
Price$10.25
Change-$0.01 (-0.10%)
Volume$8.42M
Capitalization38.4B
HLBBF vs HLN Comparison Chart in %
Loading...
HLBBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLBBF vs. HLN commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLBBF is a Hold and HLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (HLBBF: $6.00 vs. HLN: $10.25)
Brand notoriety: HLBBF and HLN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HLBBF: 176% vs. HLN: 53%
Market capitalization -- HLBBF: $4.85B vs. HLN: $38.4B
HLBBF [@Pharmaceuticals: Other] is valued at $4.85B. HLN’s [@Pharmaceuticals: Other] market capitalization is $38.4B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLBBF’s FA Score shows that 0 FA rating(s) are green whileHLN’s FA Score has 0 green FA rating(s).

  • HLBBF’s FA Score: 0 green, 5 red.
  • HLN’s FA Score: 0 green, 5 red.
According to our system of comparison, both HLBBF and HLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLBBF’s TA Score shows that 4 TA indicator(s) are bullish while HLN’s TA Score has 4 bullish TA indicator(s).

  • HLBBF’s TA Score: 4 bullish, 2 bearish.
  • HLN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, HLN is a better buy in the short-term than HLBBF.

Price Growth

HLBBF (@Pharmaceuticals: Other) experienced а +12.15% price change this week, while HLN (@Pharmaceuticals: Other) price change was -1.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

HLN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($38.4B) has a higher market cap than HLBBF($4.85B). HLN has higher P/E ratio than HLBBF: HLN (29.23) vs HLBBF (13.25). HLN YTD gains are higher at: 8.671 vs. HLBBF (-2.439). HLBBF has higher annual earnings (EBITDA): 2.94B vs. HLN (2.35B). HLBBF has more cash in the bank: 2.88B vs. HLN (994M). HLBBF has less debt than HLN: HLBBF (5.22B) vs HLN (9.46B). HLBBF has higher revenues than HLN: HLBBF (18.9B) vs HLN (11.3B).
HLBBFHLNHLBBF / HLN
Capitalization4.85B38.4B13%
EBITDA2.94B2.35B125%
Gain YTD-2.4398.671-28%
P/E Ratio13.2529.2345%
Revenue18.9B11.3B167%
Total Cash2.88B994M290%
Total Debt5.22B9.46B55%
TECHNICAL ANALYSIS
Technical Analysis
HLBBFHLN
RSI
ODDS (%)
Bearish Trend 4 days ago
57%
Bullish Trend 4 days ago
53%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
35%
Bullish Trend 4 days ago
59%
Momentum
ODDS (%)
Bullish Trend 4 days ago
42%
Bearish Trend 4 days ago
35%
MACD
ODDS (%)
Bullish Trend 4 days ago
30%
Bearish Trend 4 days ago
41%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
46%
Bearish Trend 4 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
50%
Bearish Trend 4 days ago
36%
Advances
ODDS (%)
N/A
Bullish Trend 25 days ago
58%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
48%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
70%
Bullish Trend 4 days ago
65%
Aroon
ODDS (%)
Bullish Trend 4 days ago
63%
Bearish Trend 4 days ago
40%
View a ticker or compare two or three
Interact to see
Advertisement
HLBBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ABLG30.93N/A
N/A
Abacus FCF International Leaders ETF
ITM45.46-0.03
-0.07%
VanEck Intermediate Muni ETF
EEMO16.93-0.03
-0.21%
Invesco S&P Emerging Markets Mom ETF
FAAR27.79-0.13
-0.47%
First Trust Alt Abs Ret Strat ETF
EDD5.21-0.03
-0.57%
Morgan Stanley Emerging Markets Domestic Debt Fund

HLBBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLBBF has been loosely correlated with DRRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HLBBF jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLBBF
1D Price
Change %
HLBBF100%
N/A
DRRX - HLBBF
38%
Loosely correlated
+0.02%
BNXTF - HLBBF
27%
Poorly correlated
+3.55%
HLUBF - HLBBF
19%
Poorly correlated
N/A
HLNCF - HLBBF
8%
Poorly correlated
-5.74%
HLN - HLBBF
4%
Poorly correlated
-0.10%
More

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with TAK. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then TAK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
-0.10%
TAK - HLN
41%
Loosely correlated
-0.52%
ZTS - HLN
35%
Loosely correlated
+0.06%
PRGO - HLN
27%
Poorly correlated
-0.22%
ALKS - HLN
26%
Poorly correlated
-0.52%
BHC - HLN
26%
Poorly correlated
-0.84%
More